MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TORO-GOYCO, E.
Right arrow Articles by PRESTON, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TORO-GOYCO, E.
Right arrow Articles by PRESTON, A. M.

Molecular Pharmacology, Vol 14, 130-137, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

On the Action of Dgr9-Tetrahydrocannabinol as an Inhibitor of Sodium- and Potassium-Dependent Adenosine Triphosphatase

EFRAÍN TORO-GOYCO 1, M. B. RODRÍGUEZ 1, and A. M. PRESTON 1

1 Department of Biochemistry and Nutrition, University of Puerto Rico School of Medicine, San Juan, Puerto Rico 00936

Chromatographically pure Dgr9-tetrahydrocannabinol (Dgr9-THC) was tested in vitro for inhibitory activity on sodium- and potassium-stimulated ATPase (ATP phosphohydrolase, EC 3.6.1.3) from various sources. Concentrations of 3 µM Dgr9-THC inhibited by 50% enzyme preparations with specific activities of 1200-1500 nmoles of Pi per minute per milligram of protein. Rat brain ATPases were much more sensitive to Dgr9-THC than to equal concentrations of ouabain. The kinetics of inhibition of electric eel ATPases seemed to be noncompetitive with respect to ATP. Rat brain ouabain-insensitive ATPases were also inhibited by Dgr9-THC, and preliminary kinetic data indicated that inhibition is competitive with respect to ATP. In Ehrlich ascites tumor cells (107 cells/ flask), 60 µM Dgr9-THC inhibited nucleoside ([3H]thymidine) incorporation without exerting any significant effect on the viability of cells as measured by O2 consumption. Particulate ATPases isolated from cells exposed to Dgr9-THC were found to have significantly lower specific activity than cells in control media, 123 ± 36 compared with 172 ± 16 nmoles of Pi per minute per milligram of protein (p < 0.005, n = 16). The hypothesis is advanced that several of the observed physiological effects of Dgr9-THC can be explained on the basis of its ATPase-inhibitory activity.

Note:
ACKNOWLEDGMENTS We thank Professor L. S. Harris, Department of Pharmacology, Medical College of Virginia, for his generous gift of Dgr9-THC, and Professor J. del Castillo, Neurobiology Institute, this institution, for the electric eels. We thank Drs. J. M. Cimadevilla and H. Jering for their criticisms and suggestions, and Mr. Juan Caloca for the illustrations.

Submitted on April 22, 1977
Accepted on August 18, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics